Executive summary. Traceability programs fail when serialized data is treated as a file transfer. The operational work is validating what arrives and resolving what does not.
Definition
The Drug Supply Chain Security Act establishes federal requirements for tracing and verifying certain prescription drugs as they move through the United States supply chain.
Treat every handoff as evidence
A traceability record answers what moved, between whom, when, and under which identifier. It needs enough provenance that an investigation months later does not depend on somebody finding the right email thread.
Before treating a transaction as operationally complete, validate identity, association, completeness, and exception state. Arrival tells you only that a file transferred.
Exceptions are the workflow
Most teams handle the ordinary case without difficulty. The design pressure sits in missing data, delayed responses, mismatched identifiers, suspect product, and product that cannot be verified.
Give each exception an owner, a deadline, a containment action, and a documented resolution. An exception log with no workflow behind it accumulates into an archive of unresolved risk.
Frequently asked questions
Is DSCSA compliance a technology project?
Technology carries the data. Written procedures, accountable review, and an exception response path are what make the control operate.
Referenced standards and further reading
- FDA: Drug Supply Chain Security Act ↗U.S. Food and Drug Administration
Related articles
DSCSA product tracing: the operational record →
Enhanced drug distribution security and serialized product data →
Suspect and illegitimate product: designing the response path →